Drug intelligence / Profile preview

l-glutaminase

Development stage
Preclinical
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes
Administration
Intravenous (experimental/clinical, For Cancer Trials)[3], In Vitro (cell Culture Studies, Research)
01

Overview

**L-glutaminase** is an enzyme (amidohydrolase, EC 3.5.1.2) that catalyzes the hydrolysis of L-glutamine to L-glutamate and ammonia. It is studied and applied primarily as an *anticancer agent*, depleting L-glutamine in the extracellular environment, which inhibits the proliferation and survival of cancer cells that rely heavily on glutamine for metabolic functions and growth[3][4]. The enzyme's cytotoxic and anticancer effects have been shown in various cancer cell lines (e.g., leukemia, breast, colorectal, liver cancers), where glutaminase-mediated glutamine deprivation promotes cell death, protein synthesis arrest, and oxidative stress[3][4]. L-glutaminase is sourced from microbes (e.g., Streptomyces, Klebsiella, Halomonas, Alcaligenes, Pseudomonas), and microbial forms are preferred for large-scale production due to cultivation efficiency. L-glutaminase also has industrial relevance as a flavor enhancer, contributing to umami taste[3][4].

Other names
glutamine amidohydrolaseEC 3.5.1.2EC3.5.1.2EC-3.5.1.2L-glutamine amidohydrolase

Beyond the preview

Go deeper on l-glutaminase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on l-glutaminase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call